Literature DB >> 24073296

Omega-3 fatty acids for the prevention of breast cancer: an update and state of the science.

Neil M Iyengar1, Clifford A Hudis, Ayca Gucalp.   

Abstract

The quantity and makeup of dietary fat intake are known to impact human health. Use of Omega-3 (ω-3) polyunsaturated fatty acid (PUFA) supplements has gained increasing attention for a variety of purported health benefits, including cancer prevention. Preclinical evidence has been encouraging and recent studies have expanded our understanding of the mechanisms by which ω-3 PUFAs may protect against breast cancer. However, epidemiologic studies have yielded mixed results. Recent population studies have attempted to delineate factors that may influence the effects of ω-3 PUFAs such as total fat intake and the ratio of ω-3 to ω-6 PUFA intake. Several clinical trials, including some currently ongoing, are investigating novel strategies that favorably alter endogenous fatty acid profiles in an effort to develop clinically feasible prevention methods. Identification of well-defined subpopulations that are most likely to benefit from a targeted prevention approach will likely be crucial in this effort.

Entities:  

Keywords:  Breast cancer; diet; fatty acids; fish oil; inflammation; metabolism; nutrition; obesity; omega-3 polyunsaturated fatty acids; omega-6 polyunsaturated fatty acids; prevention; risk factors

Year:  2013        PMID: 24073296      PMCID: PMC3780443          DOI: 10.1007/s12609-013-0112-1

Source DB:  PubMed          Journal:  Curr Breast Cancer Rep        ISSN: 1943-4588


  47 in total

1.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Authors:  Lisa D Yee; Joanne L Lester; Rachel M Cole; Julia R Richardson; Jason C Hsu; Yan Li; Amy Lehman; Martha A Belury; Steven K Clinton
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

2.  Fatty acids and breast cancer: the role of stem cells.

Authors:  Kent L Erickson; Neil E Hubbard
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-04-02       Impact factor: 4.006

Review 3.  Essential fatty acids in health and chronic disease.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

4.  Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231.

Authors:  Vincent Blanckaert; Lionel Ulmann; Virginie Mimouni; Johann Antol; Lucile Brancquart; Benoît Chénais
Journal:  Int J Oncol       Date:  2010-03       Impact factor: 5.650

5.  Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China.

Authors:  Jackilen Shannon; Irena B King; Johanna W Lampe; Dao Li Gao; Roberta M Ray; Ming-Gang Lin; Helge Stalsberg; David B Thomas
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

6.  Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation.

Authors:  Ki Sung Kang; Pan Wang; Noriko Yamabe; Masayuki Fukui; Taylor Jay; Bao Ting Zhu
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

7.  Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.

Authors:  D M O'Hanlon; H Fitzsimons; J Lynch; S Tormey; C Malone; H F Given
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

Review 8.  Multi-targeted therapy of cancer by omega-3 fatty acids.

Authors:  Isabelle M Berquin; Iris J Edwards; Yong Q Chen
Journal:  Cancer Lett       Date:  2008-05-13       Impact factor: 8.679

Review 9.  Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.

Authors:  H Tapiero; G Nguyen Ba; P Couvreur; K D Tew
Journal:  Biomed Pharmacother       Date:  2002-07       Impact factor: 6.529

10.  Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.

Authors:  Kotha Subbaramaiah; Patrick G Morris; Xi Kathy Zhou; Monica Morrow; Baoheng Du; Dilip Giri; Levy Kopelovich; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Discov       Date:  2012-01-27       Impact factor: 39.397

View more
  6 in total

1.  Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: a randomized clinical trial of dietary fish and n-3 fatty acid capsules.

Authors:  Shana Straka; Joanne L Lester; Rachel M Cole; Rebecca R Andridge; Sarah Puchala; Angela M Rose; Steven K Clinton; Martha A Belury; Lisa D Yee
Journal:  Mol Nutr Food Res       Date:  2015-07-07       Impact factor: 5.914

Review 2.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

3.  Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer.

Authors:  Oana Zanoaga; Ancuta Jurj; Lajos Raduly; Roxana Cojocneanu-Petric; Enrique Fuentes-Mattei; Oscar Wu; Cornelia Braicu; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

Review 4.  Docosahexaenoic Acid in Combination with Dietary Energy Restriction for Reducing the Risk of Obesity Related Breast Cancer.

Authors:  Andrea Manni; Karam El-Bayoumy; Henry Thompson
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

5.  Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model.

Authors:  Michael A Leslie; Salma A Abdelmagid; Kate Perez; William J Muller; David Wl Ma
Journal:  Lipids Health Dis       Date:  2014-06-11       Impact factor: 3.876

6.  Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer.

Authors:  H Chung; Y S Lee; R Mayoral; D Y Oh; J T Siu; N J Webster; D D Sears; J M Olefsky; L G Ellies
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.